The Doctor Is In - Biotech in July
A conversation regarding the Therapeutics market and why it is standing out from other segments of biotech and health sciences.
Other topics covered:
Urogen (URGN) and its triple-digit performance
What is going on with SMID stocks
An assessment of obesity drugs and its potential impact on markets and society